ArticleMolecular imaging and radionuclide therapy2017

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer.

Steven M Larson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.